Dr. Marty Makary, President Trump's nominee to lead the Food and Drug Administration, faced questions from senators about ...

Martin Makary, President Donald Trump's nominee to run the U.S. FDA, on Thursday promised to convene the agency's vaccine ...

Marty Makary, Trump’s pick for FDA director, faces his first test as he testifies before the Senate health committee.

Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple ...

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...

For Dominick Dunlap's family, the risks of blood clots associated with feminizing hormone therapy appear to have led to ...

U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could ...

House Passes Chronic Disease Bill To Expand Coverage Under HDHPs New legislation advanced by a voice vote March 4 would codify 14 pre-deductible healthcare services through high-deductible health ...

FDA nominee Marty Makary pledges to review the cancellation of a key flu vaccine meeting, addressing concerns over ...

Questioned by senators at a Thursday hearing, President Trump's FDA nominee said he would reevaluate which scientific topics ...

Dr. Marty Makary, Trump's nominee for FDA Commissioner, breezed through his confirmation hearing despite tough questions from Democrats and Republicans.